# Designing the Ideal Artificial Spectrum
## What Perfect Artificial Light Would Look Like

*Part 24 of the Light Science Series*

---


After exploring the problems with current lighting, a natural question emerges: What would ideal artificial light actually look like?

This isn't a theoretical exercise. It's a design specification that could be built today-if manufacturers understood what matters.


## The Core Principle: Minimal Viable Spectrum

The goal isn't to replicate the full solar spectrum. Much of sunlight's bandwidth isn't needed indoors, and some wavelengths cause damage without corresponding benefits.

**Target bandwidth: 450-620nm (170nm)**

Include only wavelengths with essential biological functions. Exclude those that create uncoupled oxidative stress.


## The Spectral Decision Matrix

### EXCLUDE: 380-450nm (Violet + Short Blue)

**Violet (380-420nm): Critical exclusion**

Damage pathways:
- Retinal lipofuscin (A2E) photooxidation
- Skin photoaging (only 5nm above UV-A cutoff)
- High photon energy (3.0-3.1 eV)
- No melanopsin benefit (peak is at 480nm, not here)

Missing protection:
- No compensatory NIR (natural ratio 1:8.5)
- No UV-triggered antioxidant upregulation (Nrf2 pathway)

**Note:** Vitamin D synthesis requires UV-B (280-315nm), which is already absent indoors-this is not a violet light issue.

**Verdict:** Zero benefit, maximum irreversible damage-exclude entirely.

**Short Blue (420-450nm): High risk**

Damage pathways:
- Peak blue light hazard (IEC 62471 peaks at 435-440nm)
- Riboflavin photoexcitation â†’ folate depletion
- Retinal pigment epithelium damage
- Lipid peroxidation in photoreceptors

Minimal benefit:
- Melanopsin activation only 60% of peak
- S-cone activation (but 460-480nm is sufficient)

**Verdict:** High damage, redundant function-exclude.


### INCLUDE: 450-495nm (Long Blue + Cyan)

**Long Blue (450-480nm): Essential**

Functions:
- Melanopsin activation (approaching peak)
- S-cone activation (sufficient at this range)
- Circadian entrainment

Damage reduction:
- Blue light hazard drops 60% from 440nm to 470nm
- Moderate folate depletion (40% less than 440nm)

**Implementation:**
- Peak at 470-480nm (maximize melanopsin, minimize BLH)
- Avoid sharp 450nm peak (common in cheap LEDs)
- Target: 15-20% of total irradiance

**Verdict:** Essential for circadian function, manageable risk.

**Cyan (480-495nm): Highly beneficial**

Functions:
- Maximum melanopsin activation (480nm = peak)
- S-cone + M-cone transition
- Color perception support

Damage:
- Negligible (blue light hazard <10% of peak)

**Implementation:**
- Peak at 480-485nm
- Target: 10-15% of total irradiance

**Verdict:** Maximum circadian benefit, minimal damage.


### INCLUDE: 495-570nm (Green)

**Green (495-570nm): Essential and safe**

Functions:
- M-cone peak activation (530nm)
- Photopic vision (maximum sensitivity)
- Virtually zero oxidative stress

Damage:
- None identified (most biologically inert visible wavelength)

**Implementation:**
- Broad plateau 510-560nm
- Peak at 530-550nm
- Target: 25-30% of total irradiance (highest safe contribution)

**Verdict:** Maximum safety, essential for vision.


### INCLUDE: 570-620nm (Yellow + Orange)

**Yellow (570-590nm): Beneficial**

Functions:
- L-cone activation (approaching peak)
- M-cone activation (tail)
- Warm color perception
- Zero melanopsin (evening-safe)

Damage:
- None

**Implementation:**
- Smooth transition from green to orange
- Target: 15-20% of total irradiance

**Verdict:** Safe, supports color rendering.

**Orange (590-620nm): Essential for evening**

Functions:
- L-cone peak activation (565nm with tail into this range)
- Warm color rendering
- Minimal melanopsin (<5% of peak)
- Evening-appropriate

Damage:
- None (melanopsin-safe, no CCO activation yet)

**Implementation:**
- Smooth plateau 590-615nm
- Sharp cutoff at 620nm
- Target: 20-25% of total irradiance

**Verdict:** Essential for evening use, zero stress.


### EXCLUDE: 620-780nm (Red + NIR) for Standard Lighting

**Why exclude red and NIR from primary lighting?**

This may seem counterintuitive given earlier discussion of NIR benefits. Here's the reasoning:

**For general ambient lighting:**
- Red (620-700nm) activates CCO oxidized state
- Without NIR completion (810nm), activation is incomplete
- Better to not activate than to activate incompletely
- Sharp cutoff at 620nm avoids initiating stressed pathway

**For supplemental use (separate fixtures):**
- Dedicated red/NIR panels provide complete photocycle
- 660nm + 810nm together = balanced activation
- Keep separate from ambient illumination

**Verdict:** For ambient lighting, stop at 620nm. Supplement with dedicated red/NIR devices.


## The Ideal Spectrum Profile

### Morning/Daytime Configuration

| Band | Wavelength | % of Total | Purpose |
|------|------------|------------|---------|
| Long Blue | 450-480nm | 15-20% | Circadian activation |
| Cyan | 480-495nm | 10-15% | Peak melanopsin |
| Green | 495-570nm | 25-30% | Vision (highest) |
| Yellow | 570-590nm | 15-20% | Color rendering |
| Orange | 590-620nm | 20-25% | Warmth, evening transition |

**Cutoffs:**
- Hard cutoff below 450nm (no violet, no short blue)
- Hard cutoff above 620nm (no red, no NIR)

### Evening Configuration

| Band | Wavelength | % of Total | Purpose |
|------|------------|------------|---------|
| Long Blue | 450-480nm | 5% | Minimal |
| Cyan | 480-495nm | 5% | Minimal |
| Green | 495-570nm | 30% | Vision maintained |
| Yellow | 570-590nm | 25% | Warmer |
| Orange | 590-620nm | 35% | Maximum warmth |


## Key Metrics for Ideal Spectrum

### Blue:Red Ratio

**Optimal:** 1.5-2.0:1 for daytime

This provides:
- Adequate circadian signaling
- Metabolic safety (hunger regulation)
- Reasonable color rendering

**Current LEDs:** Often 4-6:1 (problematic)

### S-Cone Content

**Optimal by time:**
- Morning (Phase 1): 15-18%
- Daytime (sustained): 8-12%
- Evening: <5%

**Current cold LEDs:** 20-25% always (problematic for sustained use)

### Melanopic/Photopic Ratio

**Optimal:** 0.6-0.8 for daytime

Higher than warm LEDs (~0.3-0.4) but lower than cold LEDs (~1.0).

Balanced circadian activation without overwhelming melanopsin.


## What This Would Mean in Practice

### Compared to Current Cold LED

| Metric | Current Cold LED | Ideal Spectrum | Improvement |
|--------|------------------|----------------|-------------|
| Violet (380-420nm) | 3-5% | 0% | Eliminates oxidative stress |
| Short blue (420-450nm) | 15-18% | 0% | 60% less folate loss |
| Blue peak | 445-450nm | 470-480nm | 40% less BLH |
| Blue:Red | 5-6:1 | 1.5-2:1 | Metabolic safety |
| NIR | 0% | 0% (ambient) | Equal |

### Compared to Current Warm LED

| Metric | Current Warm LED | Ideal Spectrum | Improvement |
|--------|------------------|----------------|-------------|
| Morning circadian | Poor | Excellent | Phase 1 support |
| Melanopsin | 30-40% of cold | 60-70% of cold | Better circadian |
| Color rendering | Good | Good | Equal |
| Evening safety | Good | Good | Equal |


## The Red/NIR Supplement Question

For complete photobiological support, the ideal system would include:

**Ambient lighting (450-620nm):**
- General illumination
- Circadian timing
- No CCO activation (avoids incomplete cycling)

**Supplemental red/NIR (660nm + 810nm):**
- Dedicated devices
- Complete CCO photocycle
- Used for 10-20 minutes daily
- Not part of general ambient

This separation allows:
- Ambient light without CCO stress
- Complete CCO activation when desired
- No incomplete photocycles from mixed sources


## Implementation Challenges

### Why This Doesn't Exist Yet

1. **Manufacturing:** Sharp spectral cutoffs require different phosphors
2. **Cost:** Custom spectra more expensive than standard
3. **Awareness:** Lighting industry focused on efficiency and CCT
4. **Standards:** No regulatory driver for optimal biology

### What Would Be Needed

1. **Custom phosphor development** (450nm cutoff, 620nm cutoff)
2. **Multi-channel LED systems** (separately controllable bands)
3. **Time-based programming** (automatic spectral shifting)
4. **Industry education** (beyond lumens and CCT)

### Interim Solutions

Until ideal fixtures exist:
- Use warm LEDs as baseline
- Add brief daylight LED exposure for morning
- Supplement with red/NIR devices separately
- Manage duration carefully


## Key Takeaways

1. **Ideal spectrum: 450-620nm only** (170nm bandwidth)
2. **Exclude violet and short blue** (damage without benefit)
3. **Peak at 470-480nm** for circadian (not 445nm)
4. **Hard cutoff at 620nm** (avoid incomplete CCO activation)
5. **Supplement red/NIR separately** (complete photocycle when desired)


*This concludes the Light Science Series. The goal has been to translate spectral measurements and photobiology research into actionable understanding. Light shapes our biology in ways we're only beginning to appreciate-and the choices we make about our light environment matter more than most realize.*


## Technical Appendix

### Spectral Band Summary

| Band | Wavelength | Decision | Rationale |
|------|------------|----------|-----------|
| UV-A | 320-400nm | Exclude | Indoor: no benefit |
| Violet | 380-420nm | Exclude | Oxidative stress, no melanopsin benefit |
| Short Blue | 420-450nm | Exclude | Peak BLH, folate depletion |
| Long Blue | 450-480nm | Include | Circadian, reduced BLH |
| Cyan | 480-495nm | Include | Peak melanopsin |
| Green | 495-570nm | Include | Vision, zero damage |
| Yellow | 570-590nm | Include | Color rendering |
| Orange | 590-620nm | Include | Evening appropriate |
| Red | 620-700nm | Exclude* | Incomplete CCO risk |
| NIR | 700-1000nm | Exclude* | Not in ambient; supplement separately |

*Exclude from ambient lighting; include in dedicated therapeutic devices.

### Implementation Specification

**Daytime fixture:**
- CCT equivalent: ~4500K visual appearance
- CRI: >90 (without violet/short blue contribution)
- Melanopic/Photopic: 0.6-0.8
- Flicker: <3%
- Spectral cutoffs: 450nm and 620nm (hard)

**Evening fixture:**
- CCT equivalent: ~2200K visual appearance
- Minimal cyan/blue (shift energy to yellow/orange)
- Melanopic/Photopic: <0.3
- Same cutoff principles
